0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Neurological Biomarkers Market Research Report 2023
Published Date: January 2023
|
Report Code: QYRE-Auto-38M8825
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Neurological Biomarkers Market Outlook 2022
BUY CHAPTERS

Global Neurological Biomarkers Market Research Report 2023

Code: QYRE-Auto-38M8825
Report
January 2023
Pages:104
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Neurological Biomarkers Market Size

The global Neurological Biomarkers market was valued at US$ 6937 million in 2022 and is anticipated to reach US$ 15480 million by 2029, witnessing a CAGR of 12.0% during the forecast period 2023-2029.

Neurological Biomarkers Market

Neurological Biomarkers Market

A biomarker is a characteristic that can be objectively measured and evaluated as an indicator of a physiological as well as a pathological process or pharmacological response to a therapeutic intervention. Examples of classical biomarkers are measurable alterations in blood pressure and blood glucose in diabetes mellitus.
The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global Neurological Biomarkers key players include Thermo Fisher Scientific, Merck, Quest Diagnostics, Abbott, etc. Global top four manufacturers hold a share about 25%.
North America is the largest market, with a share over 55%, followed by Europe, and Asia-Pacific, both have a share over 35 percent.
In terms of product, Proteomics is the largest segment, with a share about 30%. And in terms of application, the largest application is Proteomics, followed by Drug Discovery, Personalized Medicine, etc.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Neurological Biomarkers, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Neurological Biomarkers.
The Neurological Biomarkers market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Neurological Biomarkers market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Neurological Biomarkers manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.

Scope of Neurological Biomarkers Market Report

Report Metric Details
Report Name Neurological Biomarkers Market
Accounted market size in 2022 US$ 6937 in million
Forecasted market size in 2029 US$ 15480 million
CAGR 12.0%
Base Year 2022
Forecasted years 2023 - 2029
Segment by Type
  • Proteomics
  • Genomics
  • Imaging
  • Bioinformatics
  • Others
Segment by Application
  • Diagnostics
  • Drug Discovery
  • Personalized Medicine
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Thermo Fisher Scientific, Merck, Quest Diagnostics, Abbott, Roche, Illumina, Bio-Rad Laboratories, QIAGEN, Myriad RBM, Cisbio Bioassays, Athena Diagnostics, BGI, Wuxi APP, Aepodia, Proteome Sciences, Genewiz
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Neurological Biomarkers manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Neurological Biomarkers in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report.
  • COVID-19 and Russia-Ukraine War Influence Analysis
  • The readers in the section will understand how the Neurological Biomarkers market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
  • Reasons to Buy This Report
  • This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Neurological Biomarkers market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
  • This report will help stakeholders to understand the global industry status and trends of Neurological Biomarkers and provides them with information on key market drivers, restraints, challenges, and opportunities.
  • This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
  • This report stays updated with novel technology integration, features, and the latest developments in the market
  • This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Neurological Biomarkers industry.
  • This report helps stakeholders to gain insights into which regions to target globally
  • This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Neurological Biomarkers.
  • This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Neurological Biomarkers manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Neurological Biomarkers in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Analysis of sales channel, distributors and customers
  • Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 10: sales and revenue forecast, global and regional, by Type and by Application. It provides a quantitative analysis of the market size and development potential of each market segment in the next six years.
  • Chapter 11: The main points and conclusions of the report.

FAQ for this report

How fast is Neurological Biomarkers Market market growing?

Ans: The Neurological Biomarkers Market market witnessing a CAGR of 12.0% during the forecast period 2023-2029.

What is the Neurological Biomarkers Market market size in 2029?

Ans: The global Neurological Biomarkers market was valued at US$ 6937 million in 2022 and is anticipated to reach US$ 15480 million by 2029, witnessing a CAGR of 12.0% during the forecast period 2023-2029.

1 Neurological Biomarkers Market Overview
1.1 Product Overview and Scope of Neurological Biomarkers
1.2 Neurological Biomarkers Segment by Type
1.2.1 Global Neurological Biomarkers Market Value Comparison by Type (2023-2029)
1.2.2 Proteomics
1.2.3 Genomics
1.2.4 Imaging
1.2.5 Bioinformatics
1.2.6 Others
1.3 Neurological Biomarkers Segment by Application
1.3.1 Global Neurological Biomarkers Market Value by Application: (2023-2029)
1.3.2 Diagnostics
1.3.3 Drug Discovery
1.3.4 Personalized Medicine
1.3.5 Others
1.4 Global Neurological Biomarkers Market Size Estimates and Forecasts
1.4.1 Global Neurological Biomarkers Revenue 2018-2029
1.4.2 Global Neurological Biomarkers Sales 2018-2029
1.4.3 Global Neurological Biomarkers Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Neurological Biomarkers Market Competition by Manufacturers
2.1 Global Neurological Biomarkers Sales Market Share by Manufacturers (2018-2023)
2.2 Global Neurological Biomarkers Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Neurological Biomarkers Average Price by Manufacturers (2018-2023)
2.4 Global Neurological Biomarkers Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Neurological Biomarkers, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Neurological Biomarkers, Product Type & Application
2.7 Neurological Biomarkers Market Competitive Situation and Trends
2.7.1 Neurological Biomarkers Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Neurological Biomarkers Players Market Share by Revenue
2.7.3 Global Neurological Biomarkers Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Neurological Biomarkers Retrospective Market Scenario by Region
3.1 Global Neurological Biomarkers Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Neurological Biomarkers Global Neurological Biomarkers Sales by Region: 2018-2029
3.2.1 Global Neurological Biomarkers Sales by Region: 2018-2023
3.2.2 Global Neurological Biomarkers Sales by Region: 2024-2029
3.3 Global Neurological Biomarkers Global Neurological Biomarkers Revenue by Region: 2018-2029
3.3.1 Global Neurological Biomarkers Revenue by Region: 2018-2023
3.3.2 Global Neurological Biomarkers Revenue by Region: 2024-2029
3.4 North America Neurological Biomarkers Market Facts & Figures by Country
3.4.1 North America Neurological Biomarkers Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Neurological Biomarkers Sales by Country (2018-2029)
3.4.3 North America Neurological Biomarkers Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Neurological Biomarkers Market Facts & Figures by Country
3.5.1 Europe Neurological Biomarkers Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Neurological Biomarkers Sales by Country (2018-2029)
3.5.3 Europe Neurological Biomarkers Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Neurological Biomarkers Market Facts & Figures by Country
3.6.1 Asia Pacific Neurological Biomarkers Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Neurological Biomarkers Sales by Country (2018-2029)
3.6.3 Asia Pacific Neurological Biomarkers Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Neurological Biomarkers Market Facts & Figures by Country
3.7.1 Latin America Neurological Biomarkers Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Neurological Biomarkers Sales by Country (2018-2029)
3.7.3 Latin America Neurological Biomarkers Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Neurological Biomarkers Market Facts & Figures by Country
3.8.1 Middle East and Africa Neurological Biomarkers Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Neurological Biomarkers Sales by Country (2018-2029)
3.8.3 Middle East and Africa Neurological Biomarkers Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Neurological Biomarkers Sales by Type (2018-2029)
4.1.1 Global Neurological Biomarkers Sales by Type (2018-2023)
4.1.2 Global Neurological Biomarkers Sales by Type (2024-2029)
4.1.3 Global Neurological Biomarkers Sales Market Share by Type (2018-2029)
4.2 Global Neurological Biomarkers Revenue by Type (2018-2029)
4.2.1 Global Neurological Biomarkers Revenue by Type (2018-2023)
4.2.2 Global Neurological Biomarkers Revenue by Type (2024-2029)
4.2.3 Global Neurological Biomarkers Revenue Market Share by Type (2018-2029)
4.3 Global Neurological Biomarkers Price by Type (2018-2029)
5 Segment by Application
5.1 Global Neurological Biomarkers Sales by Application (2018-2029)
5.1.1 Global Neurological Biomarkers Sales by Application (2018-2023)
5.1.2 Global Neurological Biomarkers Sales by Application (2024-2029)
5.1.3 Global Neurological Biomarkers Sales Market Share by Application (2018-2029)
5.2 Global Neurological Biomarkers Revenue by Application (2018-2029)
5.2.1 Global Neurological Biomarkers Revenue by Application (2018-2023)
5.2.2 Global Neurological Biomarkers Revenue by Application (2024-2029)
5.2.3 Global Neurological Biomarkers Revenue Market Share by Application (2018-2029)
5.3 Global Neurological Biomarkers Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Thermo Fisher Scientific
6.1.1 Thermo Fisher Scientific Corporation Information
6.1.2 Thermo Fisher Scientific Description and Business Overview
6.1.3 Thermo Fisher Scientific Neurological Biomarkers Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Thermo Fisher Scientific Neurological Biomarkers Product Portfolio
6.1.5 Thermo Fisher Scientific Recent Developments/Updates
6.2 Merck
6.2.1 Merck Corporation Information
6.2.2 Merck Description and Business Overview
6.2.3 Merck Neurological Biomarkers Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Merck Neurological Biomarkers Product Portfolio
6.2.5 Merck Recent Developments/Updates
6.3 Quest Diagnostics
6.3.1 Quest Diagnostics Corporation Information
6.3.2 Quest Diagnostics Description and Business Overview
6.3.3 Quest Diagnostics Neurological Biomarkers Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Quest Diagnostics Neurological Biomarkers Product Portfolio
6.3.5 Quest Diagnostics Recent Developments/Updates
6.4 Abbott
6.4.1 Abbott Corporation Information
6.4.2 Abbott Description and Business Overview
6.4.3 Abbott Neurological Biomarkers Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Abbott Neurological Biomarkers Product Portfolio
6.4.5 Abbott Recent Developments/Updates
6.5 Roche
6.5.1 Roche Corporation Information
6.5.2 Roche Description and Business Overview
6.5.3 Roche Neurological Biomarkers Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Roche Neurological Biomarkers Product Portfolio
6.5.5 Roche Recent Developments/Updates
6.6 Illumina
6.6.1 Illumina Corporation Information
6.6.2 Illumina Description and Business Overview
6.6.3 Illumina Neurological Biomarkers Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Illumina Neurological Biomarkers Product Portfolio
6.6.5 Illumina Recent Developments/Updates
6.7 Bio-Rad Laboratories
6.6.1 Bio-Rad Laboratories Corporation Information
6.6.2 Bio-Rad Laboratories Description and Business Overview
6.6.3 Bio-Rad Laboratories Neurological Biomarkers Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Bio-Rad Laboratories Neurological Biomarkers Product Portfolio
6.7.5 Bio-Rad Laboratories Recent Developments/Updates
6.8 QIAGEN
6.8.1 QIAGEN Corporation Information
6.8.2 QIAGEN Description and Business Overview
6.8.3 QIAGEN Neurological Biomarkers Sales, Revenue and Gross Margin (2018-2023)
6.8.4 QIAGEN Neurological Biomarkers Product Portfolio
6.8.5 QIAGEN Recent Developments/Updates
6.9 Myriad RBM
6.9.1 Myriad RBM Corporation Information
6.9.2 Myriad RBM Description and Business Overview
6.9.3 Myriad RBM Neurological Biomarkers Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Myriad RBM Neurological Biomarkers Product Portfolio
6.9.5 Myriad RBM Recent Developments/Updates
6.10 Cisbio Bioassays
6.10.1 Cisbio Bioassays Corporation Information
6.10.2 Cisbio Bioassays Description and Business Overview
6.10.3 Cisbio Bioassays Neurological Biomarkers Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Cisbio Bioassays Neurological Biomarkers Product Portfolio
6.10.5 Cisbio Bioassays Recent Developments/Updates
6.11 Athena Diagnostics
6.11.1 Athena Diagnostics Corporation Information
6.11.2 Athena Diagnostics Neurological Biomarkers Description and Business Overview
6.11.3 Athena Diagnostics Neurological Biomarkers Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Athena Diagnostics Neurological Biomarkers Product Portfolio
6.11.5 Athena Diagnostics Recent Developments/Updates
6.12 BGI
6.12.1 BGI Corporation Information
6.12.2 BGI Neurological Biomarkers Description and Business Overview
6.12.3 BGI Neurological Biomarkers Sales, Revenue and Gross Margin (2018-2023)
6.12.4 BGI Neurological Biomarkers Product Portfolio
6.12.5 BGI Recent Developments/Updates
6.13 Wuxi APP
6.13.1 Wuxi APP Corporation Information
6.13.2 Wuxi APP Neurological Biomarkers Description and Business Overview
6.13.3 Wuxi APP Neurological Biomarkers Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Wuxi APP Neurological Biomarkers Product Portfolio
6.13.5 Wuxi APP Recent Developments/Updates
6.14 Aepodia
6.14.1 Aepodia Corporation Information
6.14.2 Aepodia Neurological Biomarkers Description and Business Overview
6.14.3 Aepodia Neurological Biomarkers Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Aepodia Neurological Biomarkers Product Portfolio
6.14.5 Aepodia Recent Developments/Updates
6.15 Proteome Sciences
6.15.1 Proteome Sciences Corporation Information
6.15.2 Proteome Sciences Neurological Biomarkers Description and Business Overview
6.15.3 Proteome Sciences Neurological Biomarkers Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Proteome Sciences Neurological Biomarkers Product Portfolio
6.15.5 Proteome Sciences Recent Developments/Updates
6.16 Genewiz
6.16.1 Genewiz Corporation Information
6.16.2 Genewiz Neurological Biomarkers Description and Business Overview
6.16.3 Genewiz Neurological Biomarkers Sales, Revenue and Gross Margin (2018-2023)
6.16.4 Genewiz Neurological Biomarkers Product Portfolio
6.16.5 Genewiz Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Neurological Biomarkers Industry Chain Analysis
7.2 Neurological Biomarkers Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Neurological Biomarkers Production Mode & Process
7.4 Neurological Biomarkers Sales and Marketing
7.4.1 Neurological Biomarkers Sales Channels
7.4.2 Neurological Biomarkers Distributors
7.5 Neurological Biomarkers Customers
8 Neurological Biomarkers Market Dynamics
8.1 Neurological Biomarkers Industry Trends
8.2 Neurological Biomarkers Market Drivers
8.3 Neurological Biomarkers Market Challenges
8.4 Neurological Biomarkers Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
    Table 1. Global Neurological Biomarkers Market Value Comparison by Type (2023-2029) & (US$ Million)
    Table 2. Global Neurological Biomarkers Market Value Comparison by Application (2023-2029) & (US$ Million)
    Table 3. Global Neurological Biomarkers Market Competitive Situation by Manufacturers in 2022
    Table 4. Global Neurological Biomarkers Sales (K Units) of Key Manufacturers (2018-2023)
    Table 5. Global Neurological Biomarkers Sales Market Share by Manufacturers (2018-2023)
    Table 6. Global Neurological Biomarkers Revenue (US$ Million) by Manufacturers (2018-2023)
    Table 7. Global Neurological Biomarkers Revenue Share by Manufacturers (2018-2023)
    Table 8. Global Market Neurological Biomarkers Average Price (USD/Unit) of Key Manufacturers (2018-2023)
    Table 9. Global Key Players of Neurological Biomarkers, Industry Ranking, 2021 VS 2022 VS 2023
    Table 10. Global Key Manufacturers of Neurological Biomarkers, Manufacturing Sites & Headquarters
    Table 11. Global Key Manufacturers of Neurological Biomarkers, Product Type & Application
    Table 12. Global Key Manufacturers of Neurological Biomarkers, Date of Enter into This Industry
    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Neurological Biomarkers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neurological Biomarkers as of 2022)
    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 16. Global Neurological Biomarkers Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 17. Global Neurological Biomarkers Sales by Region (2018-2023) & (K Units)
    Table 18. Global Neurological Biomarkers Sales Market Share by Region (2018-2023)
    Table 19. Global Neurological Biomarkers Sales by Region (2024-2029) & (K Units)
    Table 20. Global Neurological Biomarkers Sales Market Share by Region (2024-2029)
    Table 21. Global Neurological Biomarkers Revenue by Region (2018-2023) & (US$ Million)
    Table 22. Global Neurological Biomarkers Revenue Market Share by Region (2018-2023)
    Table 23. Global Neurological Biomarkers Revenue by Region (2024-2029) & (US$ Million)
    Table 24. Global Neurological Biomarkers Revenue Market Share by Region (2024-2029)
    Table 25. North America Neurological Biomarkers Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 26. North America Neurological Biomarkers Sales by Country (2018-2023) & (K Units)
    Table 27. North America Neurological Biomarkers Sales by Country (2024-2029) & (K Units)
    Table 28. North America Neurological Biomarkers Revenue by Country (2018-2023) & (US$ Million)
    Table 29. North America Neurological Biomarkers Revenue by Country (2024-2029) & (US$ Million)
    Table 30. Europe Neurological Biomarkers Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 31. Europe Neurological Biomarkers Sales by Country (2018-2023) & (K Units)
    Table 32. Europe Neurological Biomarkers Sales by Country (2024-2029) & (K Units)
    Table 33. Europe Neurological Biomarkers Revenue by Country (2018-2023) & (US$ Million)
    Table 34. Europe Neurological Biomarkers Revenue by Country (2024-2029) & (US$ Million)
    Table 35. Asia Pacific Neurological Biomarkers Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
    Table 36. Asia Pacific Neurological Biomarkers Sales by Region (2018-2023) & (K Units)
    Table 37. Asia Pacific Neurological Biomarkers Sales by Region (2024-2029) & (K Units)
    Table 38. Asia Pacific Neurological Biomarkers Revenue by Region (2018-2023) & (US$ Million)
    Table 39. Asia Pacific Neurological Biomarkers Revenue by Region (2024-2029) & (US$ Million)
    Table 40. Latin America Neurological Biomarkers Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 41. Latin America Neurological Biomarkers Sales by Country (2018-2023) & (K Units)
    Table 42. Latin America Neurological Biomarkers Sales by Country (2024-2029) & (K Units)
    Table 43. Latin America Neurological Biomarkers Revenue by Country (2018-2023) & (US$ Million)
    Table 44. Latin America Neurological Biomarkers Revenue by Country (2024-2029) & (US$ Million)
    Table 45. Middle East & Africa Neurological Biomarkers Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 46. Middle East & Africa Neurological Biomarkers Sales by Country (2018-2023) & (K Units)
    Table 47. Middle East & Africa Neurological Biomarkers Sales by Country (2024-2029) & (K Units)
    Table 48. Middle East & Africa Neurological Biomarkers Revenue by Country (2018-2023) & (US$ Million)
    Table 49. Middle East & Africa Neurological Biomarkers Revenue by Country (2024-2029) & (US$ Million)
    Table 50. Global Neurological Biomarkers Sales (K Units) by Type (2018-2023)
    Table 51. Global Neurological Biomarkers Sales (K Units) by Type (2024-2029)
    Table 52. Global Neurological Biomarkers Sales Market Share by Type (2018-2023)
    Table 53. Global Neurological Biomarkers Sales Market Share by Type (2024-2029)
    Table 54. Global Neurological Biomarkers Revenue (US$ Million) by Type (2018-2023)
    Table 55. Global Neurological Biomarkers Revenue (US$ Million) by Type (2024-2029)
    Table 56. Global Neurological Biomarkers Revenue Market Share by Type (2018-2023)
    Table 57. Global Neurological Biomarkers Revenue Market Share by Type (2024-2029)
    Table 58. Global Neurological Biomarkers Price (USD/Unit) by Type (2018-2023)
    Table 59. Global Neurological Biomarkers Price (USD/Unit) by Type (2024-2029)
    Table 60. Global Neurological Biomarkers Sales (K Units) by Application (2018-2023)
    Table 61. Global Neurological Biomarkers Sales (K Units) by Application (2024-2029)
    Table 62. Global Neurological Biomarkers Sales Market Share by Application (2018-2023)
    Table 63. Global Neurological Biomarkers Sales Market Share by Application (2024-2029)
    Table 64. Global Neurological Biomarkers Revenue (US$ Million) by Application (2018-2023)
    Table 65. Global Neurological Biomarkers Revenue (US$ Million) by Application (2024-2029)
    Table 66. Global Neurological Biomarkers Revenue Market Share by Application (2018-2023)
    Table 67. Global Neurological Biomarkers Revenue Market Share by Application (2024-2029)
    Table 68. Global Neurological Biomarkers Price (USD/Unit) by Application (2018-2023)
    Table 69. Global Neurological Biomarkers Price (USD/Unit) by Application (2024-2029)
    Table 70. Thermo Fisher Scientific Corporation Information
    Table 71. Thermo Fisher Scientific Description and Business Overview
    Table 72. Thermo Fisher Scientific Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 73. Thermo Fisher Scientific Neurological Biomarkers Product
    Table 74. Thermo Fisher Scientific Recent Developments/Updates
    Table 75. Merck Corporation Information
    Table 76. Merck Description and Business Overview
    Table 77. Merck Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 78. Merck Neurological Biomarkers Product
    Table 79. Merck Recent Developments/Updates
    Table 80. Quest Diagnostics Corporation Information
    Table 81. Quest Diagnostics Description and Business Overview
    Table 82. Quest Diagnostics Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 83. Quest Diagnostics Neurological Biomarkers Product
    Table 84. Quest Diagnostics Recent Developments/Updates
    Table 85. Abbott Corporation Information
    Table 86. Abbott Description and Business Overview
    Table 87. Abbott Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 88. Abbott Neurological Biomarkers Product
    Table 89. Abbott Recent Developments/Updates
    Table 90. Roche Corporation Information
    Table 91. Roche Description and Business Overview
    Table 92. Roche Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 93. Roche Neurological Biomarkers Product
    Table 94. Roche Recent Developments/Updates
    Table 95. Illumina Corporation Information
    Table 96. Illumina Description and Business Overview
    Table 97. Illumina Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 98. Illumina Neurological Biomarkers Product
    Table 99. Illumina Recent Developments/Updates
    Table 100. Bio-Rad Laboratories Corporation Information
    Table 101. Bio-Rad Laboratories Description and Business Overview
    Table 102. Bio-Rad Laboratories Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 103. Bio-Rad Laboratories Neurological Biomarkers Product
    Table 104. Bio-Rad Laboratories Recent Developments/Updates
    Table 105. QIAGEN Corporation Information
    Table 106. QIAGEN Description and Business Overview
    Table 107. QIAGEN Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 108. QIAGEN Neurological Biomarkers Product
    Table 109. QIAGEN Recent Developments/Updates
    Table 110. Myriad RBM Corporation Information
    Table 111. Myriad RBM Description and Business Overview
    Table 112. Myriad RBM Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 113. Myriad RBM Neurological Biomarkers Product
    Table 114. Myriad RBM Recent Developments/Updates
    Table 115. Cisbio Bioassays Corporation Information
    Table 116. Cisbio Bioassays Description and Business Overview
    Table 117. Cisbio Bioassays Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 118. Cisbio Bioassays Neurological Biomarkers Product
    Table 119. Cisbio Bioassays Recent Developments/Updates
    Table 120. Athena Diagnostics Corporation Information
    Table 121. Athena Diagnostics Description and Business Overview
    Table 122. Athena Diagnostics Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 123. Athena Diagnostics Neurological Biomarkers Product
    Table 124. Athena Diagnostics Recent Developments/Updates
    Table 125. BGI Corporation Information
    Table 126. BGI Description and Business Overview
    Table 127. BGI Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 128. BGI Neurological Biomarkers Product
    Table 129. BGI Recent Developments/Updates
    Table 130. Wuxi APP Corporation Information
    Table 131. Wuxi APP Description and Business Overview
    Table 132. Wuxi APP Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 133. Wuxi APP Neurological Biomarkers Product
    Table 134. Wuxi APP Recent Developments/Updates
    Table 135. Aepodia Corporation Information
    Table 136. Aepodia Description and Business Overview
    Table 137. Aepodia Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 138. Aepodia Neurological Biomarkers Product
    Table 139. Aepodia Recent Developments/Updates
    Table 140. Proteome Sciences Corporation Information
    Table 141. Proteome Sciences Description and Business Overview
    Table 142. Proteome Sciences Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 143. Proteome Sciences Neurological Biomarkers Product
    Table 144. Proteome Sciences Recent Developments/Updates
    Table 145. Genewiz Corporation Information
    Table 146. Genewiz Description and Business Overview
    Table 147. Genewiz Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 148. Genewiz Neurological Biomarkers Product
    Table 149. Genewiz Recent Developments/Updates
    Table 150. Key Raw Materials Lists
    Table 151. Raw Materials Key Suppliers Lists
    Table 152. Neurological Biomarkers Distributors List
    Table 153. Neurological Biomarkers Customers List
    Table 154. Neurological Biomarkers Market Trends
    Table 155. Neurological Biomarkers Market Drivers
    Table 156. Neurological Biomarkers Market Challenges
    Table 157. Neurological Biomarkers Market Restraints
    Table 158. Research Programs/Design for This Report
    Table 159. Key Data Information from Secondary Sources
    Table 160. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Neurological Biomarkers
    Figure 2. Global Neurological Biomarkers Market Value Comparison by Type (2023-2029) & (US$ Million)
    Figure 3. Global Neurological Biomarkers Market Share by Type in 2022 & 2029
    Figure 4. Proteomics Product Picture
    Figure 5. Genomics Product Picture
    Figure 6. Imaging Product Picture
    Figure 7. Bioinformatics Product Picture
    Figure 8. Others Product Picture
    Figure 9. Global Neurological Biomarkers Market Value Comparison by Application (2023-2029) & (US$ Million)
    Figure 10. Global Neurological Biomarkers Market Share by Application in 2022 & 2029
    Figure 11. Diagnostics
    Figure 12. Drug Discovery
    Figure 13. Personalized Medicine
    Figure 14. Others
    Figure 15. Global Neurological Biomarkers Revenue, (US$ Million), 2018 VS 2022 VS 2029
    Figure 16. Global Neurological Biomarkers Market Size (2018-2029) & (US$ Million)
    Figure 17. Global Neurological Biomarkers Sales (2018-2029) & (K Units)
    Figure 18. Global Neurological Biomarkers Average Price (USD/Unit) & (2018-2029)
    Figure 19. Neurological Biomarkers Report Years Considered
    Figure 20. Neurological Biomarkers Sales Share by Manufacturers in 2022
    Figure 21. Global Neurological Biomarkers Revenue Share by Manufacturers in 2022
    Figure 22. The Global 5 and 10 Largest Neurological Biomarkers Players: Market Share by Revenue in 2022
    Figure 23. Neurological Biomarkers Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
    Figure 24. Global Neurological Biomarkers Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
    Figure 25. North America Neurological Biomarkers Sales Market Share by Country (2018-2029)
    Figure 26. North America Neurological Biomarkers Revenue Market Share by Country (2018-2029)
    Figure 27. U.S. Neurological Biomarkers Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 28. Canada Neurological Biomarkers Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 29. Europe Neurological Biomarkers Sales Market Share by Country (2018-2029)
    Figure 30. Europe Neurological Biomarkers Revenue Market Share by Country (2018-2029)
    Figure 31. Germany Neurological Biomarkers Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 32. France Neurological Biomarkers Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 33. U.K. Neurological Biomarkers Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 34. Italy Neurological Biomarkers Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 35. Russia Neurological Biomarkers Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 36. Asia Pacific Neurological Biomarkers Sales Market Share by Region (2018-2029)
    Figure 37. Asia Pacific Neurological Biomarkers Revenue Market Share by Region (2018-2029)
    Figure 38. China Neurological Biomarkers Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 39. Japan Neurological Biomarkers Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 40. South Korea Neurological Biomarkers Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 41. India Neurological Biomarkers Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 42. Australia Neurological Biomarkers Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 43. Taiwan Neurological Biomarkers Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 44. Indonesia Neurological Biomarkers Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 45. Thailand Neurological Biomarkers Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 46. Malaysia Neurological Biomarkers Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 47. Philippines Neurological Biomarkers Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 48. Latin America Neurological Biomarkers Sales Market Share by Country (2018-2029)
    Figure 49. Latin America Neurological Biomarkers Revenue Market Share by Country (2018-2029)
    Figure 50. Mexico Neurological Biomarkers Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 51. Brazil Neurological Biomarkers Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 52. Argentina Neurological Biomarkers Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 53. Middle East & Africa Neurological Biomarkers Sales Market Share by Country (2018-2029)
    Figure 54. Middle East & Africa Neurological Biomarkers Revenue Market Share by Country (2018-2029)
    Figure 55. Turkey Neurological Biomarkers Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 56. Saudi Arabia Neurological Biomarkers Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 57. U.A.E Neurological Biomarkers Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 58. Global Sales Market Share of Neurological Biomarkers by Type (2018-2029)
    Figure 59. Global Revenue Market Share of Neurological Biomarkers by Type (2018-2029)
    Figure 60. Global Neurological Biomarkers Price (USD/Unit) by Type (2018-2029)
    Figure 61. Global Sales Market Share of Neurological Biomarkers by Application (2018-2029)
    Figure 62. Global Revenue Market Share of Neurological Biomarkers by Application (2018-2029)
    Figure 63. Global Neurological Biomarkers Price (USD/Unit) by Application (2018-2029)
    Figure 64. Neurological Biomarkers Value Chain
    Figure 65. Neurological Biomarkers Production Process
    Figure 66. Channels of Distribution (Direct Vs Distribution)
    Figure 67. Distributors Profiles
    Figure 68. Bottom-up and Top-down Approaches for This Report
    Figure 69. Data Triangulation
    Figure 70. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS